logo
Select company
Select metric
$ 232.84MGross Profit
VS
Market
51
Sector
78
Industry
91
History
100
$ 15.41Close
$ 9.55 - $ 70 52-Week Range
Ticker Information

Ticker

KROS

Company Name

KEROS THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

KEROS THERAPEUTICS INC - Gross Profit Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KROS - GP Historical data
DateGross Profit
6/30/2025$ 232.84M
3/31/2025$ 214.71M
12/31/2024$ 3.55M
9/30/2024$ 651K
6/30/2024$ 271K
3/31/2024$ 234K
12/31/2023$ 151K
9/30/2023$ 8K
6/30/2023$ 0
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KEROS THERAPEUTICS INC's latest trailing twelve months (TTM) GP stands at $ 0.
  • Over the past 5 years, KEROS THERAPEUTICS INC's average GP has been $ 28.04M.
  • The median GP for KEROS THERAPEUTICS INC during this period was $ 234K
  • KEROS THERAPEUTICS INC reached its highest GP over the past 5 years at $ 232.84M.
  • The lowest GP recorded by KEROS THERAPEUTICS INC in the same timeframe $ 0

KEROS THERAPEUTICS INC's GP vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

GP Benchmarks
CompanyGP
MRVI : MARAVAI LIFESCIENCES HOLDINGS INC $ 62.83MDNA : GINKGO BIOWORKS HOLDINGS INC $ 182.32MDAWN : DAY ONE BIOPHARMACEUTICALS INC $ 176.42MRIGL : RIGEL PHARMACEUTICALS INC $ 245.19MSTOK : STOKE THERAPEUTICS INC $ 199.89MXNCR : XENCOR INC $ 146.93MAKBA : AKEBIA THERAPEUTICS INC $ 151.66MANAB : ANAPTYSBIO INC $ 123.16MRGNX : REGENXBIO INC $ 128.43MPHAT : PHATHOM PHARMACEUTICALS INC $ 99.11M

Definition of Gross Profit

[Income Statement] Gross Profit is a financial metric that demonstrates how sales [Revenue] cover the direct costs associated with the production of goods [CoR].

KROS - Gross Profit, Last 5 years

$ 0

Minimum

Dec 31, 2020

$ 232.84M

Maximum

Jun 30, 2025

$ 28.04M

Average

$ 234K

Median

GP Benchmark Analysis

The chart above depicts the distribution of GP for companies in the Total Stock Market. The average GP of the companies is $ 245.13M with a standard deviation of $ 328.2M.
The following table provides additional summary stats:
GP in the Market:
filtered constituents3.34K
min$ -790.38M
max$ 1.32B
average$ 245.13M
median$ 92.73M
std$ 328.2M